Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[PMID: 2909253] PubMed record related to this compound for laboratory literature review
Semaglutide is the active ingredient in three drugs currently approved by the Food and Drug Administration (FDA)
Effect of Weekly Subcutaneous GLP-1 Shots vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial
Canadas Health Canada had approved two generic versions of Ozempic and was reviewing submissions for seven further products by mid-2026
Anvisa notes it is among the first agencies globally to approve this type of product
doi: 10.1073/pnas.85.10.3653
US$ 21.15
US$ 27.32
US$ 23.12
US$ 27.06
